Overview

Niemann-Pick disease (NPD) is a genetic disorder that is characterised by low levels of acid sphingomyelinase (ASMD), an enzyme that metabolizes sphingomyelin into ceramide and phosphocholine, thus leading to lysosomal storage diseases. Therefore, SM and its precursor lipids begin to accumulate in lysosomes, principally in macrophages, when synthesising eLB 1 and eLB 2 fail. None of these macrophages filled with lipids remain free-floating but settle down in various organs like the liver, spleen, lungs, and brain and cause hepatosplenomegaly, anaemia, lung problems, and neurological manifestations respectively.¹

NPD is a genetic disorder where the body does not produce enough of the enzyme sphingomyelinase (ASMD) to break down certain fatty substances. As a result, these fats build up inside cells, especially in immune cells called macrophages. Over time, the fat-filled cells collect in different organs such as the liver, spleen, lungs and brain. This can cause a swollen liver and spleen, anaemia, breathing problems, and difficulties with movement and thinking.

Niemann-Pick disease can occur at various stages of life but predominantly impacts children. There is no known cure for the condition, and it can be deadly at times. The focus of treatment is to assist individuals in managing their symptoms.²

Classification

There are different types of Niemann-Pick diseases present, which are categorised according to age. The common types are:¹

1. Type A: It is referred to as an infantile neurovisceral form characterised by significantly decreased acid sphingomyelinase (ASM) activity and typically results in death before the age of three. It impacts younger kids and leads to neurological deficits and hindered growth

This form appears in infancy and is the most severe. It happens because of very low levels of an important enzyme called ASM. Babies often develop serious neurological problems and growth delays, and in some cases, they do not live beyond the age of three.

2. Type B: It has milder symptoms and involves fluctuating visceral symptoms with little neurological impact. The predominant visceral symptoms found in these phenotypes typically consist of hepatosplenomegaly, thrombocytopenia, and interstitial lung disease

This type is milder and mostly affects organs like the liver, spleen, and lungs, but usually does not cause major brain problems. Children or adults with this type may have an enlarged liver and spleen, low platelets, or lung issues.

3. Type C: It presents with a varied clinical presentation, involving systemic, neurologic, and psychiatric aspects. It typically impacts grown-ups but can arise at any stage of life.

This type can appear at any age, but is more often seen in older children or adults. It affects not only the body but also the brain and even mental health. Symptoms can include problems with movement, balance, or memory.

4. Type D: It refers to an uncommon and serious manifestation of the illness that usually appears in babies or young children. Children diagnosed with type D disease frequently do not live beyond early childhood

5. Type E:  It is a rarer form of NPD that emerges in adulthood. Typical neurologic symptoms of NPD in childhood cases are cognitive or motor delay, vertical supranuclear gaze palsy, ataxia, dysarthria, dysphagia, and dystonia

This is a rare type seen in adults. It can cause problems with movement, speech, swallowing, or muscle control.

Both Niemann-Pick disease types A and B result from mutations in the SMPD1 gene. ASMD is another name for the condition known as acid sphingomyelinase deficiency. These genetic alterations result in the absence or impaired function of the enzyme sphingomyelinase. This enzyme is necessary for the breakdown and utilisation of sphingomyelin lipids in cells. The accumulation of these fats results in cellular damage, leading to cell death eventually.²

Types A and B are caused in a gene called SMPD1. This gene normally makes an enzyme (ASM) that helps break down certain fats in the body. Without enough of this enzyme, fats build up in cells, which damages and eventually kills them.

Causes

Niemann-Pick is a result of a genetic mutation in the SMPD1 gene that influences the manufacture of enzymes that assist in the breakdown and metabolism of fat molecules. These specific enzymes are known as sphingomyelinases, and they are vital in dictating how lipids are processed in a cell. In the absence of these enzymes or their failed functioning, fats may stack up to dangerous concentrations within particular organs and tissues and lead to Niemann-Pick disease symptoms.

Niemann-Pick diseases follow the autosomal recessive form of inheritance, which implies that one needs to inherit two copies of the mutated gene from both parents. It should be noted that people possessing only one copy of the changed gene can be called carriers who do not experience symptoms but can pass the mutation to future generations.³

People who carry only one copy of that gene usually don’t show symptoms, but they can pass the gene on to their children.

Risk factors

The type of Niemann-Pick disease determines the risk factors associated with it. The disorder is the result of alterations in genes that are inherited within families. Although the condition can occur in any population.²

1. Type A is more common among individuals of Ashkenazi Jewish ancestry
2. Type B is more common in individuals of North African origin
3. Type C is present in various populations, with a higher frequency found among individuals of Acadian and Bedouin heritage
4. Having one child with Niemann-Pick disease increases the likelihood of having another child with the same condition

Signs and symptoms

Symptoms vary. Other health conditions may cause similar symptoms. At the beginning of the illness, only a small number of symptoms may be present. A person may never have all the symptoms.⁴

Type A typically starts within the first few months of life. Symptoms may include:

• Abdominal swelling within 3 to 6 months
• A red spot resembling a cherry is located at the rear of the eye
• Feeding difficulties
• Loss of early motor skills

Type B symptoms are usually milder. They happen during the later years of childhood or in the teenage stage. Abdominal swelling may occur in young children. There is hardly any brain and nervous system participation, such as a decline in motor abilities. Certain kids might experience recurrent respiratory infections.

Types C and C1 usually affect school-age children., it can happen from early childhood to the adult years. Symptoms may include:

• Difficulty in moving limbs can cause an unsteady gait, clumsiness, and walking issues.
• Enlarged spleen
• Enlarged liver
• Jaundice at (or shortly after) birth
• Learning difficulties and intellectual decline
• Seizures
• Slurred, irregular speech
• Unexpected decrease in muscle strength, which could result in accidents.
• Tremors
• Trouble moving the eyes up and down
• Interstitial lung disease
• Decreased diffusion capacity
• Recurrent lung infections
• Thrombocytopenia
• Hypercholesterolemia
• Impaired growth of long bones
• Slowed mineralisation of bones
• Coxa vara

Diagnosis

Niemann-Pick diagnosis is very challenging due to symptoms that are similar to other diseases, making it difficult to distinguish. The disease is very rare; therefore, diagnosis is important.^3,5 The following are diagnostic tools used:

1.  Blood tests: There are some enzymes and fats in the blood which play a role in diagnosing Niemann-Pick disease
2. Genetic testing: This examination enables one to obtain the specificity of the gene responsible for the illness
3. It is also possible to have other tests that utilise pictures, like computerised tomography and magnetic resonance imaging, which can help form a picture of the brain or any other organ that has an issue. Thus, tests such as neurological tests or evaluations of the brain and the nervous system can be used in evaluating the status of the individuals for the presence of disease and the degree of its impact on the patient
4. Liver and spleen biopsy: This involves cutting a small opening using a scalpel and then stripping one or two grams of liver or spleen to check for tissue that causes disease
5. Another method related to bone marrow is Bone Marrow Aspiration, formally known as Bone Marrow Biopsy, which entails the removal of soft tissue commonly from the pelvis or sternum. This procedure is not very sensitive but common in NPC patients to determine the existence of macrophages that bind to receptor cholesterol or foam cells in the bone marrow
6. The ‘eyelid’ in dissected view, so to speak: a slit-lamp examination in the eye
7. Liver biopsy could be unnecessary because, in place of it, procedures such as chorionic villus sampling or amniocentesis are used in prenatal tests. Following childbirth, tropical diseases can best be diagnosed by liver biopsy, which may entail the microscopic examination of liver samples

Diagnosing Niemann-Pick's disease might involve collaboration among various specialists, like a geneticist, neurologist, and gastroenterologist.

Other conditions to consider 

Other conditions involving the storage of substances within lysosomes should be considered, particularly Gaucher disease, Tay-Sachs disease, and Metachromatic leukodystrophy. Gaucher disease also shows hepatosplenomegaly and cytopenias as symptoms, but bone pain and lesions are more noticeable.¹

When diagnosing Niemann-Pick disease, doctors also think about other lysosomal storage diseases that can look similar. These include Gaucher disease, Tay-Sachs disease, and Metachromatic leukodystrophy.

•  Gaucher disease: It often causes an enlarged liver and spleen and low blood cell counts. However, bone pain and bone damage are more common in Gaucher disease. It is caused by a lack of the enzyme glucocerebrosidase, which leads to the build-up of a fat-like substance called glucocerebroside inside the cell
• Tay-Sachs disease: This condition mainly affects the nervous system. Children with Tay-Sachs may show developmental delays, muscle weakness, and progressive loss of abilities. A classic sign is a “cherry-red spot” seen in the eye during an exam. Unlike Niemann-Pick, Tay-Sachs does not usually cause liver or spleen enlargement. It is caused by a missing enzyme called hexosaminidase A, leading to a harmful build-up of  GM2 gangliosides in nerve cells
• Metachromatic leukodystrophy: This disease damages the protective covering (myelin) of nerves in both the brain and body. Symptoms can include problems with balance, difficulty walking, and other neurological issues

Treatment

There is no definitive cure for any type of Niemann-Pick disease. Treatment options are restricted and rely on supportive actions. At present, there is no effective therapy available for Type A illness. Research is being conducted on using enzyme replacement therapy, bone marrow transplantation, and gene therapy for type B disease. The emergence of new medications such as Miglustat is beginning to be seen in the management of type C disease. Miglustat inhibits the enzyme glucosylceramide synthase, which plays a role in the production of glycosphingolipids. Accumulation of these molecules is excessive in Niemann-Pick disease⁵.

Even though there is no full cure for Niemann-Pick disease, researchers are investigating new therapies that can stop the progression of the disease. Children who are affected usually succumb to infections or gradual impairment of the central nervous system.

Supportive therapies

Treatment for Niemann-Pick disease of any kind is based on symptoms and can involve various therapies:

1. Physical and occupational therapy can assist in maintaining movement abilities for as long as feasible. Speech therapy can help with issues related to speaking and swallowing
2. Nutrition therapy. This includes special foods that can be added to the diet when swallowing becomes difficult
3. Oxygen therapy. This can help if the lungs are affected and problems with breathing happen

Complication

Niemann-Pick disease is a progressive disease, and quite often, complications develop with time.¹

1. The initial involvement of the liver can transform into fulminant hepatic failure
2. Deterioration of the lungs can result in respiratory insufficiency
3. Progressive neurodegeneration can cause dementia, seizures, and schizophrenia-like psychosis
4. Severe thrombocytopenia can result in internal or external bleeding
5. Coronary artery and valvular heart disease
6. Bones become deformed, causing enlarged bone marrow cavities, thinned cortical bone, or coxa vara

Prognosis

1. Type A: It is almost always fatal, and affected children are unlikely to live beyond 4 years of age
2. Type B: These children have a slightly better prognosis than type A and may live till late childhood or early adulthood. However, they develop many complications from the disease, so the quality is not so good
3. Type C: The prognosis depends on the time of the initial presentation. If it affects infancy, the chances are very poor for survival beyond 5 years of age. If it affects after 5 years, then patients may live to the age of 20 years. However, each patient has a slightly different outlook depending on the severity and presentation of the disease¹

Summary

Niemann-Pick disease (NPD) is a rare genetic disorder caused by the deficiency of an enzyme called acid sphingomyelinase, leading to the accumulation of lipids in various organs. There are different types of NPD, each with distinct characteristics and prognosis. The disease mainly affects children and can result in liver and spleen enlargement, lung disease, neurological symptoms, and impaired growth. Diagnosis involves a variety of tests, including genetic testing, imaging, and biopsies. Currently, there is no cure for NPD, and treatment focuses on managing symptoms and supportive care. Complications can arise over time, resulting in serious health issues such as respiratory insufficiency, liver failure, and neurodegeneration. Prognosis varies depending on the type of NPD, with some forms being fatal in early childhood, while others may allow for survival into adulthood with significant challenges. Supportive therapies, including physical and occupational therapy, nutrition therapy, and oxygen therapy, can help improve the quality of life for individuals with NPD.